ERRATUM
Published on 19 Sep 2024
Erratum: Assessing the credibility of a drug's effects: identification and judgment of uncertainty by the Dutch Medicines Evaluation Board
doi 10.3389/fmed.2024.1486408
- 165 views
- Frontiers in Medicine
- Regulatory Science
- Research Topics
- Regulatory Science: Addressing Uncertainties in Medicines Development, Evaluation and Use
Regulatory Science: Addressing Uncertainties in Medicines Development, Evaluation and Use
3,025
Total downloads
16k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 17 Jul 2024
Assessing the credibility of a drug’s effects: identification and judgment of uncertainty by the Dutch Medicines Evaluation Board
doi 10.3389/fmed.2024.1409259
- 728 views
- 1 citation
POLICY BRIEF
Published on 24 Jun 2024
Balancing ethical norms and duties for the introduction of new medicines through conditional marketing authorization: a research agenda
doi 10.3389/fmed.2024.1408553
- 1,071 views
- 2 citations
REVIEW
Published on 23 May 2024
Leveraging patient experience data to guide medicines development, regulation, access decisions and clinical care in the EU
doi 10.3389/fmed.2024.1408636
- 3,310 views
MINI REVIEW
Published on 12 Apr 2024
Synthetic polypeptides using a biologic as a reference medicinal product – the European landscape of regulatory approvals
doi 10.3389/fmed.2024.1335928
- 1,848 views
POLICY AND PRACTICE REVIEWS
Published on 06 Mar 2024
Patient listening on social media for patient-focused drug development: a synthesis of considerations from patients, industry and regulators
doi 10.3389/fmed.2024.1274688
- 3,998 views
- 7 citations
ORIGINAL RESEARCH
Published on 08 Feb 2024
Predicting the submission frequency of periodic safety update reports: development and application of the EURD tool
doi 10.3389/fmed.2024.1299190
- 3,062 views
